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Abstract
To test the possible involvement of platelet-derived growth factor B-chain (PDGF-B) in anterograde and retrograde
degenerations of the CNS neurons, we studied the changes of PDGF-B localization and its mRNA expression in the rat retina
and optic nerve (ON) after unilateral ON transection, using immunohistochemistry and in situ hybridization. In the control retinas
immunoreactivity for PDGF-B and its mRNA expression were localized in the retinal ganglion cells (RGCs) and the nerve fiber
layer. After ON transection PDGF-B immunoreactivity in the nerve fiber layer started to decrease on post-injury day 3 or 4.
Atrophic changes in the RGCs started on day 5 just after the decrease of PDGF expression, and thereafter the RGC number
decreased. In the longitudinal section of the ON rostral to the transected site, swollen axons showed intense PDGF-B
immunoreactivity and macrophages, and some glial cells revealed a significant increase in both immunoreactivity and hybridiza-
tion signals. Based on these findings, we hypothesized that the decrease in PDGF-B in RGCs after axotomy causes the loss of
RGCs, and that increased PDGF-B expression in the ON plays a role in the cascade of tissue reactions following ON transection.
© 1998 Elsevier Science Ltd. All rights reserved.
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1. Introduction
After complete transection the optic nerve (ON) does
not regenerate spontaneously in adult mammals. Two
situations appear to underlay the inability of ON regen-
eration. The first is a marked loss of RGCs after axonal
injury, due to retrograde degeneration [1–3] [4,5]. The
second problem is that the axotomized RGCs fail to
extend their axons from the transected site [6–8]. With
a peripheral nerve graft, however, some RGCs survive
and extend their axons through the graft [9,10]. Never-
theless, the peripheral nerve graft itself is not enough to
allow all RGCs to regenerate their axons. On the other
hand, various growth factors and growth inhibitory
factors are known to be involved in tissue responses to
ON injury [11–13]. More information about the role of
the factors involved in the responses to ON transection
is required to help find a way to regenerate the ON.
Platelet-derived growth factor (PDGF) (a homod-
imer of PDGF-A or PDGF-B, or an AB heterodimer)
is a growth-regulatory molecule and first reported as a
chemoattractant for mesenchymal and glial cells [14,15].
The different PDGF isoforms bind to two receptor
types (PDGF a- and b-receptors) with different affini-
ties and induce complex and diverse functions [16,17].
From our previous studies using monoclonal antibody
to PDGF-B, we found its widespread distribution in
brain neurons [18,19] and suggested a novel role of
PDGF-B as a neurotrophic factor and:or neuronal
regulatory agent. Furthermore, brain neurons have
been reported to possess functional PDGF b-receptors
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[20] which specifically bind to PDGF-B, but have no
appreciable affinity for PDGF-A [17]. In the retina
Campochiaro et al. [21] were the first to show that both
PDGF-B and its specific b-receptors are expressed in
cultured retinal pigment epithelial cells and suggested
that PDGF-B acts as an autocrine mitogen for these
cells. In addition, a previous immunohistochemical
study demonstrated increased expression of PDGF A-
chain and b-receptors in human retinal tissue with
proliferative retinopathy [22]. These in vivo and in vitro
studies suggest that PDGF-B has some growth regulat-
ing function in the retina which also takes part in the
anterograde and retrograde changes of the retina after
ON transection. However, there has been no study on
how PDGF-B immunoreactivity and its mRNA expres-
sion are localized in the retina and ON, or their possi-
ble modification after ON transection. Thus, in the
present study, we first investigated the localization of
PDGF-B expression in the retina and ON in intact rats,
and then the changes in PDGF-B expression in the
protein and mRNA levels during the process of antero-
grade and retrograde degeneration following ON
transection.
2. Methods
Experiments were performed on 40 male Sprague-
Dawley rats, aged 12–15 weeks. The animals were
anesthetized with sodium pentobarbital. Body tempera-
ture was maintained at 37.590.5°C with a rectal ther-
mistor connected to a heating lamp. After longitudinal
incision of the meningeal sheath, the ON was com-
pletely transected unilaterably about 1 mm behind the
eyeball [23]. Care was taken to avoid damage to the
retinal blood supply. The sham operation followed the
same procedures with the exception of transection of
the ON. On post-operative days 1, 2, 3, 4, 5, 7, 10, 14
(n5 for each), both eye balls and ONs were removed
after perfusion with cold phosphate-buffered saline
(PBS). The day of the operation was defined as day
zero.
After the cornea, iris and lens were removed, retinas
with sclera and choroid were fixed overnight in methyl
Carnoy’s solution at 4°C. The ONs were fixed in the
same fixative for 2 h. The sham operated animals were
treated using the same procedures. The tissues were
embedded in paraffin, and 4 mm thick longitudinal
sections were prepared. For the general histological
examination, hematoxylin-eosin staining was applied.
PDGF-B expression was studied by immunohistochem-
istry and in situ hybridization histochemistry. Ricinus
communis agglumin-120 (RCA-1) staining and glial
fibrillary acidic protein (GFAP) immunostaining were
performed to identify microglial cells or macrophages
and astrocytes, respectively [24]. Tissues subjected to
the sham operation were used as controls.
2.1. Immunohistochemistry
We analyzed PDGF-B protein expression by im-
munohistochemistry using the streptavidin-biotin im-
munoperoxidase method [25]. The primary antibody
was mouse monoclonal antibody, PGF-007 (Mochida,
Tokyo, Japan), which recognizes both PDGF BB and
AB, but not AA [25]. After deparaffinization, endoge-
nous peroxidase activity was blocked with 0.3% H2O2,
with 1% sodium azide (Nakarai tesque, Kyoto, Japan).
After being incubated in normal rabbit serum, sections
were incubated with the primary antibody (0.2 mg:ml)
at 4°C overnight. Additional washes in PBS were fol-
lowed by an application of biotinylated rabbit anti-
mouse IgG 1 (Zymed Laboratories, San Francisco, CA)
at a dilution of 1:400 for 40 min. After washing in PBS,
horseradish peroxidase-conjugated streptavidin (Jack-
son Immunoresearch Laboratories, West Grove, PA)
was applied to the sections at a 1:5000 dilution for 40
min. The slides were visualized using 3,3%-diaminoben-
zidine (DAKO, Kyoto, Japan) with nickel anmonium
sulfate in 0.05 M Tris-buffer, pH 7.5, containing H2O2.
Sections were counterstained with methyl green (Sigma,
St. Louis, MO).
To test the specificity of the immunostaining, the
primary antibody was replaced with non-immune
mouse IgG of an equivalent concentration, or PGF-007
preincubated with a 5-M excess of synthetic PDGF-B
peptide, and the same procedure was followed (data not
shown).
To identify macrophages and microglial cells, lectin
histochemistry was performed using RCA-1 (Seika-
gaku, Tokyo, Japan), which binds specifically to brain
macrophages derived from both peripheral blood
monocytes and microglial cells [24]. After deparaffiniza-
tion, endogenous peroxidase activity was blocked by
incubating the slides with 0.3% H2O2 in methanol for
20 min. After PBS washes, incubation with RCA-1 was
performed at 4°C overnight. The slides were developed
using 3,3%-diaminobenzidine as described above. Sec-
tions were counterstained with methyl green.
Immunohistochemical staining for GFAP was carried
out using a rabbit polyclonal antibody against GFAP
(DAKO; diluted 1:600). Immunoreaction was visualized
by the streptavidin-biotin immunoperoxidase method
using a histofine SAB-PO (R) kit following the manu-
facturer’s instructions (Nichirei, Tokyo, Japan).
To identify the cell specificity of PDGF-B immunore-
activity in the distal portion of ON, immunostaining
for PDGF-B and GFAP, and lectin histochemistry for
RCA-1 were performed using a series of 1.5 mm thick
serial sections of ON from the animals on day 7.
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Fig. 1. Retinas from the control rats (a, b, c), and from the transected side on day 14 (d, e, f). (a) The RGC layer of the control consists of the
larger (arrowheads) and smaller (arrows) neurons (hematoxylin-eosin). (b) The larger neurons in the RGC layer showed moderately intense
PDGF-B immunoreactivity and the nerve fiber layer showed intense immunoreactivity for PDGF-B (PDGF-B immunostaining). (c) PDGF-B
mRNA expression observed in the larger neruons (in situ hybridization). (d) The larger neruons in the control decreased in number in the
transected side, whereas the smaller neurons were preserved (hematoxylin-eosin). (e) The immunoreactivity for PDGF-B in the nerve fiber layer,
and in the soma of the RGCs, decreased in the transected side (PDGF-B immunostaining). (f) PDGF-B mRNA expression observed in the larger
neruons in the control retina disappeared in the transected side (in situ hybridization). Scale bar50 mm.
2.2. in situ hybridization
PDGF-B mRNA expression was determined by in
situ hybridization histochemistry following the proce-
dures reported by Sasahara et al. [26].
2.2.1. Probe preparation
A 287-bp fragment of human PDGF-B cDNA span-
ning the non-coding 3% region was subcloned into plas-
mid vectors, and then run off incorporation of
digoxigenin-labeled UTP was performed to generate
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labeled antisense- and sense-cRNA probes with T7
RNA polymerase using a T7:Sp6 RNA labeling kit
(Boehringer-Mannheim, Germany). Using this digoxi-
genin-labeled antisense cRNA probe, and our northern
blot procedure, we specifically detected transcripts for
PDGF-B in RNA isolated from the rat brain [26].
2.2.2. Hybridization
Tissues were deparaffinized, hydrated and post-fixed
with 2% paraformaldehyde for 5 min. They were then
treated with 20 mg:ml proteinase K (Gibco BRL, NY)
for 5 min at 37°C followed by 2% paraformaldehyde
fixation for 5 min. Then sections were incubated with
prehybridization solution (60% formamide, Nakarai
tesque, Kyoto, Japan), 2 standard sodium citrate
(SSC) with 0.5 mg:ml sonicated salmon sperm DNA
(Pharmacia, Uppsala, Sweden), 0.5 mg:ml yeast tRNA
(Sigma), 0.5 mg:ml heparin, and 1 Denhalt’s solu-
tion, for 30 min. Subsequently sections were hybridized
overnight with 0.5 mg:ml digoxigenin-labeled cRNA
Fig. 3. Changes in the injury (I) area of the transected ON on day 7.
(a) Macrophages, as which identified due to their round swollen
cytoplasm with foamy appearance, accumulated in the I area from
day 5 (hematoxylin-eosin). (b) The macrophages showed intense
PDGF-B immunoreactivity at the perinuclear site of their cytoplasm
(PDGF-B immunostaining). Scale bar50 mm;
Fig. 2. PDGF-B and mRNA in the control ON. (a) Weak immunore-
activity for PDGF-B was observed in the interfascicular glial cells,
vascular cells and axons (PDGF-B immunostaining). (b) The interfas-
cicular glial cells also showed PDGF-B mRNA expression (in situ
hybridization). Scale bar50 mm.
probe in prehybridization solution supplemented with
10% dextran sulfate (Pharmacia), 0.1% Tween 20 at
45°C. After stringent washes in SSC, hybridization
signals were detected with alkaline phosphatase-conju-
gated anti-digoxigenin antibody (Boehringer-
Mannheim) at 1:500 dilution for 1 h. Coloring was
performed with nitroblue tetrazolium (NBT,
Boehringer-Mannheim) as per the Boehringer-
Mannheim protocol.
3. Results
3.1. Retina
In the normal and sham operation retina, various
sizes of neurons were observed in the RGC layer (Fig.
1a). The larger neurons in this layer showed moderately
strong PDGF-B immunoreactivity in their soma (Fig.
1b). PDGF-B immunoreactivity was also observed in
the horizontal cells and a small population of the
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Table 1
Selected areas of PDGF-B protein and gene expression in the injured ON
Interface areaInjury area Distal area
GFAP PDGF-B mRNA RCA-1RCA-1 GFAP PDGF-B mRNA RCA-1 GFAP PDGF-B mRNA
   –   Control ––   
Days post operation
2    2 1 –   2 3
2   2 2 2– 22 2 2 2 3
–3 2   5 3 5 5 3 3 3 3
–4   2 5 3 5 5 3 3 3 3
 3 5 5 3 53 55 3 3 3 3
7 5  5 5 5 3 5 5 3 3 3 3
 2 2 3 2 32 310 2 3 2 2
–14    2 2 2 2 2  2 2
bipolar cells of the inner nuclear layer, but not in the
neurons of the outer nuclear layer, the outer and inner
plexiform layers, or the pigment epithelial cells. The
most intense PDGF-B immunoreactivity was observed
in the axons of the retinal nerve fiber layer. Expression
of PDGF-B mRNA was observed in the larger neurons
in the RGC layer and in some neurons of the inner
nuclear layer, but not in the nerve fiber layer nor in
other tissues (Fig. 1c).
In the retina of the transected side, the larger neurons
in the RGC layer began to show atrophic change from
day 5 and decreased in number from day 7 to 14 (Fig.
1d), whereafter only smaller sized neurons remained.
The number of neuronal cells in the RGC layer per
photo of each high power microscopic view (400)
were counted at the closest proximity to the optic
nerve. A total of five HE stained sections from each
real and sham-operation animal were prepared 10 and
14 days (n5) after operation, and their mean values
and standard deviations were compared. There were a
total of 38.496.6 neurons found in the sham-controls;
among the transected animals, the number decreased to
14.793.0 (38.2% of the sham-control) on day 10, and
to 10.292.5 (26.5% of the sham-control) on day 14
after the transection. PDGF-B immunoreactivity in the
nerve fiber layer decreased markedly from day 5, and
on day 14 the nerve fibers showed only very faint
staining (Fig. 1e). The RGCs showed decreased im-
munoreactivity for PDGF-B from day 4, and also a
decrease in cell number after day 7. Only a few gan-
glion cells retained weak immunoreactivity on day 14,
whereas the PDGF-B immunostaining of neurons in
the inner nuclear layer was preserved. PDGF-B mRNA
expression in the larger neurons of the RGC layer
decreased from day 3. On day 14, little or no detectable
transcripts were demonstrated in these neuronal cells
(Fig. 1f).
3.2. Optic ner6e
The normal and sham operation optic nerves showed
only weak immunostaining for PDGF-B in the interfas-
cicular glial cells, vascular cells, and axons (Fig. 2a). in
situ hybridization histochemistry showed weak mRNA
expression in some interfascicular glial cells and the
vasculature, but not in the axons (Fig. 2b). There were
no histological differences in optic tissue among the
sham operated animals, normal animals and the con-
tralateral side of the transected animals.
From day 2 edematous and necrotic changes (injury:
I area) were observed at the cut end of the transected
optic nerves. These changes gradually increased in size
as time progressed. In this area, RCA-1 positive cells
were not observed, and GFAP-positive cells decreased
in number for a few days. On day 5, some clumped
RCA-1-positive cells were identified as macrophages
due to their round swollen cytoplasm with foamy ap-
pearance. On day 7, a large number of macrophages
were found to have accumulated not only in the I area,
where the normal structure of the ON had disappeared,
but also around the I area (Fig. 3a). PDGF-B im-
munoreactivity was first found in some macrophages in
the I area on day 5. These macrophages expressed
intense PDGF-B mRNA from day 5. On day 7, the
most intense and numerous expression of both PDGF-
B protein and mRNA was observed in the perinuclear
region of macrophages in this area (Fig. 3b). This
PDGF-B expression decreased after this and only a low
level of expression was detected on day 14 (Table 1).
The part of ON between the site of injury (I) and the
distal portion (D), was defined as the interface (IF)
area. Small RCA-1-positive cells, probably microglial
cells, and macrophages increased in number, predomi-
nantly in a closer part of IF area to I area, peaking
from day 3 to 7 (Fig. 4a). GFAP-positive cells increased
mainly at a more distal part of the IF area (Fig. 4b).
Throughout the IF area, an accumulation of PDGF-B
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immunoproducts was found in egg or oval shaped
swollen axons between day 1 and 10, peaking on days
1–3 (Fig. 5a). However, PDGF-B mRNA was not
Fig. 5. Changes in PDGF-B immunoreactivity and mRNA in the
interface (IF) area between the injury (I) and the distal portions (D)
of the transected ON on day 3. (a) Intense PDGF-B immunoreactiv-
ity was observed in swollen axons. Some reactive glial cells also
showed PDGF-B immunoreaction (PDGF-B immunostaining). (b)
Increased PDGF-B mRNA expression was observed in reactive glial
cells (in situ hybridization). Scale bar50 mm.
Fig. 4. The staining for RCA-1, GFAP, PDGF-B in the distal stump
of the transected ON on day 3. (a) RCA-1-positive cells accumulated
in the injury (I) site of the interface (IF) area (RCA-1 staining). (b)
GFAP-positive cells slightly increased in number in the IF area, but
were more distal than that of the RCA-1-positive cells. In the I area,
GFAP-positive cells were almost lost (GFAP immunostaining). (c)
PDGF-B-positive cells were very few in number in the I area, but
were abundant in the IF and D areas of the stump (PDGF-B
immunostaining). Scale bar200 mm.
localized in these degenerated axons. Both PDGF-B
protein and mRNA were expressed in reactive glial cells
in this area from day 2 to 14, peaking on day 3–7 (Fig.
5a,b). These cells with PDGF-B expression were dis-
tributed everywhere in the IF area, and the distribution
did not agree with that of either the GFAP nor the
RCA-1 positive cells (Fig. 4a,b,c).
In the distal area (D) of the transected ON, GFAP-
positive cells began to show enlarged cytoplasms and
elongated processes from day 2 which increased in
number after day 3. Small RCA-1-positive cells also
appeared in this area, but they rarely showed metamor-
phosis to macrophages. On day 14, GFAP-positive cells
showed a decrease in the number of their processes. In
these areas, PDGF-B immunoreactivity was found in
the interfascicular glial cells and vascular cells (Fig. 6a).
The number of glial cells with PDGF-B immunoreactiv-
ity increased on days 1–14, peaking on days 3–7.
Interfascicular glial cells also showed an increased
PDGF-B mRNA from day 1 (Fig. 6b).
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Analyses of serial sections from the animals on day 7
after transection revealed that in the D area the cells
with PDGF-B immunoreactivity were GFAP-positive
cells, whereas none of the RCA-1-positive cells showed
PDGF-B immunoreactivity, as shown in Fig. 7a,b,c.
4. Discussion
In the present study, concordant expression of
PDGF-B protein and mRNA was detected in the soma
of larger neurons, but not in that of smaller neurons of
the RGC layer in intact rat retinas. These larger neu-
rons with PDGF-B expression decreased in number
after transection of the ON. It has been reported that
larger and smaller neurons are present in the RGC
layer [27,28], and that larger neurons decrease selec-
tively in number after ON transection, whereas the
smaller neurons remain intact [28,29]. And, it is gener-
ally assumed that larger and smaller neurons corre-
Fig. 7. Cell types corresponding to PDGF-B-positive cells in the
distal portions (D), distant from the injury (I) and interface (IF) area,
of the transected ON on day 7. In the 1.5 mm serial sections, some
interfascicular glial cells showing PDGF-B immunoreactivity as
shown in (b) corresponded to GFAP-positive cells (arrowheads in a
and b). But RCA-1-positive cells were PDGF-B-negative (arrows in b
and c). (a) GFAP immunostaining. (b) PDGF-B immunostaining. (c)
RCA-1 immunostaining. Scale bar in (c)30 mm.
Fig. 6. Changes in PDGF-B immunoreactivity and mRNA in the
distal portions (D), distant from the injury (I) and interface (IF) area,
of the transected ON on day 3. Interfascicular glial cells in the distal
portion of the transected ON showed increased expression of both
PDGF-B protein (a) and mRNA (b) ((a) PDGF-B immunostaining,
(b) in situ hybridization). Scale bar50 mm.
spond to RGCs and displaced amacrine cells,
respectively. Therefore, we interpreted that the larger
neurons which expressed PDGF-B were RGCs. In the
literature, characterization of the PDGF-B-positive
cells in the RGC layer is controversial. Mudhar et al.
[30] regarded the PDGF-B mRNA-positive cells in the
RGC layer of young mice as mature vascular cells,
whereas Robbins et al. [22] reported in normal human
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retina that PDGF-B immunoreactivity was observed in
Mu¨ller cell end-feet and in the vasculature. Our present
study is the first to report the exact localization of
PDGF-B in RGCs. In addition to the PDGF-B protein
and mRNA expressed in the RGCs, the nerve fiber
layer showed PDGF-B immunoreactivity, but did not
express PDGF-B mRNA. The PDGF-B immunoreac-
tivity in the RGCs and optic nerve fiber layer, however,
disappeared after the ON transection. Thus, it is most
probable that PDGF-B is produced in the RGCs and
transported to the ON by axonal flow.
Our investigation revealed that PDGF-B protein and
its mRNA signal in RGCs decreased after ON transec-
tion, and that RGCs became atrophic and disappeared
with advancing days after transection. The decrease in
PDGF-B expression mentioned above preceded the cell
loss. These findings may suggest that the decrease in
PDGF-B caused the retrograde degeneration of RGCs
after ON transection. This hypothesis is supported by a
study in which a decrease in PDGF-B immunoreactiv-
ity in axotomized vagal neurons resulted in degenera-
tive changes followed by regenerative changes, whereas
no remarkable changes were observed in axotomized
hypoglossal neurons [31].
Functional PDGF b-receptors have been observed in
rat neuronal cells [20]. Phosphorylation of the PDGF
b-receptor is reported to activate protein kinase C [32]
which is abundant in the CNS and appears to be
involved in several specialized functions such as long-
term potentiation [33,34], neurotrophism [35,36] and
the release of neurotransmitters [37]. These results may
suggest that the decrease in PDGF-B production in
RGCs following ON transection causes degeneration
and reduction of RGCs through metabolic disturbances
in the cells.
Exogenous administration of growth factors, includ-
ing FGF, NGF, BDNF and CNTF, has been reported
to rescue some RGCs from retrograde degeneration
following axotomy [5,23,38]. PDGF-B is thought to be
an important endogenous neurotrophic factor for
RGCs because it decreases after axotomy followed by
cell death. PDGF-B may be one of the best candidate
growth factors to be administered exogenously to pro-
tect RGCs from retrograde cell death after ON injury.
The first change in PDGF-B at the site of ON
transection was the accumulation of PDGF-B protein
in the swollen egg or oval shaped axons. This was
followed by the accumulation of reactive cells such as
astrocytes, macrophages and microglial cells. PDGF-B
is known to be a potent mitogenic and chemoattractant
factor for glial cells and mesenchymal cells [14,15], so
rat PDGF-B derived from the swollen axons at the
transection site seems to trigger the accumulation of the
reactive cells. Numerous macrophages observed in the
stump of the transected ON showed intensive PDGF-B
expression between day 5 and 7 after ON transection.
We have also observed this macrophage response in our
previous ischemic brain study [39] and cerebral stab
wounds [40]. Macrophage-derived PDGF-B may fur-
ther participate in stimulating the accumulation of glial
cells [14,15]. In support of this view, astrocytosis after
stab wounds is dramatically suppressed by treatment
with trapidil, a specific antagonist of PDGF [41]. Al-
though we may suppose that increased PDGF-B ex-
pression in glial cells in the distal portion of ON plays
a role in the subsequent cellular cascade of wallerian
degeneration, the exact role of PDGF-B remains to be
determined in the future.
In conclusion, from the present study, it is most
probable that PDGF-B is produced in RGCs and trans-
ported to the ON. The decrease in PDGF-B in RGCs
after ON transection seems to cause the loss of RGCs,
suggesting that PDGF-B takes a part in the survival of
RGCs. Increased PDGF-B expression in the stump of
the ON may play a role in the cascade of tissue reaction
in the ON following transection.
Acknowledgements
We thank Professor Russell Ross and Professor
Richard J. Johnson from the University of Washington
(Seattle, USA), for their gift of the cDNA for the
human PDGF B-chain. We are also grateful to Ms S.
Hirayama for her excellent technical assistance. This
work was supported in part by a Grant-in-Aid for
Scientific Research (C) from the Ministry of Education,
Science, Sports and Culture of Japan (c06670223,
c08670246).
References
[1] Richardson PM, Issa VMK, Shemie S. Regeneration and retro-
grade degeneration of axons in the rat optic nerve. J Neurocytol
1982;11:949–66.
[2] Barron KD, Dentinger MP, Lrohel G, Easton SK, Mankes R.
Qualitative and ultrastructural observations on retinal ganglion
cell layer of rat after intra orbital nerve crush. J Neurocytol
1986;15:345–62.
[3] Thanos S. Alterations in the morphology of ganglion cell den-
drites in the adult rat retina after optic nerve transection and
grafting of peripheral nerve segments. Cell Tissue Res
1988;259:599–609.
[4] Villegas-Perez MP, Vidal-Sanz M, Bray G, Aguayo A. Influences
of peripheral nerve grafts on the survival and regrowth of
axotomized retinal ganglion cells in adult rat. Neuroscience
1988;3:265–80.
[5] Carmignote G, Maffei L, Candeo P, Canella R, Comelli C.
Effect of NGF on the survival of the retinal ganglion cells
following optic nerve section. J Neurosci 1989;9:1263–72.
[6] Cajal RYS. Degeneration and Regeneration of the Nervous
System. Translated by RM May, vol. 1. New York: Hafner,
1959.
[7] Schwab ME, Thoenen H. Dissociated neurons regenerate into
sciatic but not optic nerve explants in culture irrespective of
neurotrophic factors. J Neurosci 1985;5:2414–23.
A. Mekada et al. : Vision Research 38 (1998) 3031–3039 3039
[8] Cohen I, Burne J, Mckinley C, Winter J. The role of laminin and
the laminin:fibronectin receptor complex in the outgrowth of
retinal ganglion cell axons. Dev Biol 1987;122:407–18.
[9] So KF, Aguayo AJ. Lenghty regrowth of cut axons from
ganglion cells after peripheral nerve transplantation into the
retina of adult rats. Brain Res 1985;328:349–54.
[10] Vidal-Sanz M, Bray GM, Villegas-Perez MP, Thanos S, Aguago
AJ. Axonal regeneration and synapse formation in the superior
colliculus by retinal ganglion cells in the adult rat. J Neurosci
1987;7:2894–909.
[11] Caroni P, Schwab ME. Two membrane protein fractions from
rat central myelin with inhibitory properties for neurite growth
and fibroblast spreading. J Cell Biol 1988;106:1281–8.
[12] Eckenstein F, Woodward WR, Nishi R. Differential localization
and possible functions of aFGF and bFGF in the central and
peripheral nervous systems. Ann NY Acad Sci 1991;638:348–60.
[13] Berry M, Hall S, Rees L, Carlile J, Wyse JPH. Regeneration of
axons in the optic nerve of the adult Browman-Wyse (BW)
mutant rat. J Neurocytol 1992;21:426–48.
[14] Ross R, Raines EW, Bowen-Pope DF. The biology of platelet-
derived growth factor. Cell 1986;46:155–69.
[15] Heldin C-H, Westermark B. Platelet-derived growth factor:
mechanism of action and possible in vivo function. Cell Regul
1990;1:555–66.
[16] Hart CE, Forstrom JW, Kelly JD, et al. Two classes of PDGF
receptor recognize different isoforms of PDGF. Science
1988;240:1529–31.
[17] Heldin C-H, Backstorm G, Ostman A, et al. Binding of different
dimeric forms of PDGF to human fibroblasts: evidence for two
separate receptors. EMBO J 1988;7:1387–93.
[18] Sasahara M, Fries JWU, Raines EW. PDGF B-chain in neurons
of the central nervous system, posterior pituitary, and in a
transgenic model. Cell 1991;64:217–27.
[19] Sasahara A, Kott JN, Sasahara M, Raines EW, Ross R, West-
erm LM. Platelet-derived growth factor B-chain-like immunore-
activity in the developing and adult rat brain. Dev Brain Res
1992;68:41–53.
[20] Smits A, Kato M, Westermark B, Nister M, Heldin C-H, Funa
K. Neurotrophic activity of platelet-derived growth factor
(PDGF): rat neuronal cells possess functional PDGF b-type
receptors and respond to PDGF. Proc Natl Acad Sci USA
1991;88:8159–63.
[21] Campochiaro PA, Hackett SF, Vinores SA, et al. Platelet-
derived growth factor is an autocrine growth stimulator in
retinal pigmented epithelial cells. J Cell Sci 1994;107:2459–69.
[22] Robbins SG, Mixson RN, Wilson DJ. Platelet-derived growth
factor ligands and receptors immunolocalized in proliferative
retinal diseases. Invest Ophthalmol Vis Sci 1994;35:3649–63.
[23] Mey J, Thanos S. Intravitreal injections of neurotrophic factors
support the survival of axotomized retinal ganglion cells in adult
rats in vivo. Brain Res 1993;602:304–17.
[24] Hulette CM, Downey BT, Burger PC. Macrophage markers in
diagnostic neuropathology. Am J Surg Pathol 1992;16:493–9.
[25] Ross R, Masuda J, Raines EW, et al. Localization of PDGF-B
protein in macrophages in all phases of atherogenesis. Science
1990;248:1009–12.
[26] Sasahara M, Sato H, Iihara K. Expression of platelet-derived
growth factor B-chain in the mature rat brain and pituitary
gland. Mol Brain Res 1995;32:63–74.
[27] Perry VH. Evidence for an amacrine cell system in the ganglion
cell layer of the rat retina. Neuroscience 1981;6:931–44.
[28] Misantone LJ, Gershenbaum M, Murray M. Viability of retinal
ganglion cells after optic nerve crush in adult rats. J Neurocytol
1984;13:449–65.
[29] Eayrs JT. Relationship between the ganglion cell layer of the
retina and the optic nerve in the rat. Br J Ophthal 1952;36:453.
[30] Mudhar HS, Pollock RA, Wang C, Stiles CD, Richardson WD.
PDGF and its receptors in the developing rodent retina and
optic nerve. Development 1993;118:539–52.
[31] Yamada E, Hazama F. Decreased immunoreactivity of platelet-
derived growth factor B chain-like peptide after axotomy in the
dorsal motor nucleus of the vagus nerve. Brain Res
1994;651:108–14.
[32] Nishizuka Y. Turnover of inositol phospholipids and signal
transduction. Science 1984;225:1365–70.
[33] Akers RF, Lovingel DM, Colley PA, Linden DJ, Routtenberg
A. Translocation of protein kinase C activity may mediate
hippocampal long-term potentiation. Science 1986;231:587–9.
[34] Smith SJ. Progression on LTP at hippocampal synapses: a
post-synaptic Ca2trigger for memory storage. Trends Neurosci
1987;10:142–4.
[35] Hama T, Huang KP, Guroff G. Protein kinase C as a compo-
nent of a nerve growth factor-sensitive phosphorylation system
in PC12 cells. Proc Natl Acad Sci USA 1986;83:2353–7.
[36] Althaus HH, Schro¨ter J, Spoerri P, et al. Protein kinase C
stimulation enhances the process formation of adult oligoden-
drocytes and induces proliferation. J Neurosci Res 1991;29:481–
9.
[37] Yoshihara C, Saito N, Taniyama K, Tanaka C. Differential
localization of four subspecies of protein kinase C in the rat
striatum and substantia nigra. J Neurosci 1991;11:690–700.
[38] Sievers J, Hausmann B, Unsicker K, Berry M. Fibroblast growth
factors promote the survival of adult rat retinal ganglion cells
after transection of the optic nerve. Neurosci Lett 1987;76:157–
62.
[39] Iihara K, Sasahara M, Hashimoto N, Uemura Y, Kikuchi H,
Hazama F. Ischemia induces the expression of the platelet-
derived growth factor-B chain in neurons and brain
macrophages in vivo. J Cereb Blood Flow Metab 1994;14:818–
24.
[40] Takayama S, Sasahara M, Iihara K, Handa J, Hazama F.
Platelet-derived growth factor B-chain like immunoreactivity in
injured rat brain. Brain Res 1994;653:131–40.
[41] Takamiya Y, Kohsaka S, Toya S, Otani M, Mikkoshiba K,
Tsukada Y. Possible association of platelet-derived growth fac-
tor (PDGF) with the appearance of reactive astrocytes following
brain injury in situ. Brain Res 1986;383:305–9.
.
